| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,451 |
17,493 |
$440K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,848 |
10,833 |
$393K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12,271 |
9,592 |
$257K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,864 |
3,442 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,551 |
3,062 |
$132K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,306 |
2,435 |
$114K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
22,416 |
8,088 |
$97K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,630 |
10,122 |
$62K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,450 |
1,035 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
454 |
328 |
$7K |
| 87807 |
|
521 |
341 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
492 |
467 |
$153.64 |
| 81003 |
|
61 |
41 |
$22.40 |
| 71046 |
Radiologic examination, chest; 2 views |
32 |
32 |
$0.00 |